Compare MakeMyTrip Ltd (MMYT) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MakeMyTrip Ltd vs Recursion Pharmaceuticals Inc — how do they compare? MakeMyTrip Ltd trades at $56.43 (market cap $5.05B), while Recursion Pharmaceuticals Inc trades at $3.08 (market cap $1.53B). The key difference: MakeMyTrip Ltd is far larger — about 3.3× Recursion Pharmaceuticals Inc's market cap, and MakeMyTrip Ltd is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| MMYT | RXRX | |
|---|---|---|
Market Cap | $5.05B | $1.53B |
Sector | Technology | Health |
52-Week High | $103.21 | $6.79 |
52-Week Low | $36.30 | $2.84 |
Enterprise Value | $5.69B | $946.50M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About MakeMyTrip Ltd
MakeMyTrip Ltd. is a leading online travel company in India, providing a comprehensive range of travel services and products, including air tickets, hotels, holiday packages, rail tickets, and bus tickets. The company operates its primary websites and mobile apps under the brands MakeMyTrip, Goibibo, and RedBus. MMYT serves as a key intermediary in India's fragmented travel market, leveraging its platform to offer convenience and competitive pricing to consumers and businesses.
Read more on MMYT →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
